309 related articles for article (PubMed ID: 32376402)
21. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection.
Nunnari G; Sanfilippo C; Castrogiovanni P; Imbesi R; Li Volti G; Barbagallo I; Musumeci G; Di Rosa M
Exp Cell Res; 2020 Oct; 395(2):112204. PubMed ID: 32735892
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 Infection of Airway Cells.
Ehre C
N Engl J Med; 2020 Sep; 383(10):969. PubMed ID: 32877585
[No Abstract] [Full Text] [Related]
23. Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis.
Kang K; Kim HH; Choi Y
Viruses; 2020 Jul; 12(7):. PubMed ID: 32698440
[TBL] [Abstract][Full Text] [Related]
24. Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19.
Barh D; Tiwari S; Weener ME; Azevedo V; Góes-Neto A; Gromiha MM; Ghosh P
Comput Biol Med; 2020 Nov; 126():104051. PubMed ID: 33131530
[TBL] [Abstract][Full Text] [Related]
25. Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?
Edeas M; Saleh J; Peyssonnaux C
Int J Infect Dis; 2020 Aug; 97():303-305. PubMed ID: 32497811
[TBL] [Abstract][Full Text] [Related]
26. In vitro analysis of the renin-angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus.
Turk C; Turk S; Temirci ES; Malkan UY; Haznedaroglu İC
J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320928872. PubMed ID: 32490715
[TBL] [Abstract][Full Text] [Related]
27. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection.
Ramlall V; Thangaraj PM; Meydan C; Foox J; Butler D; Kim J; May B; De Freitas JK; Glicksberg BS; Mason CE; Tatonetti NP; Shapira SD
Nat Med; 2020 Oct; 26(10):1609-1615. PubMed ID: 32747830
[TBL] [Abstract][Full Text] [Related]
28. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
[TBL] [Abstract][Full Text] [Related]
29. A Dynamic Immune Response Shapes COVID-19 Progression.
Ong EZ; Chan YFZ; Leong WY; Lee NMY; Kalimuddin S; Haja Mohideen SM; Chan KS; Tan AT; Bertoletti A; Ooi EE; Low JGH
Cell Host Microbe; 2020 Jun; 27(6):879-882.e2. PubMed ID: 32359396
[TBL] [Abstract][Full Text] [Related]
30. Eosinophil-Derived Neurotoxin and Respiratory Tract Infection and Inflammation: Implications for COVID-19 Management.
Dosanjh A
J Interferon Cytokine Res; 2020 Sep; 40(9):443-445. PubMed ID: 32721252
[TBL] [Abstract][Full Text] [Related]
31. Sex-biased Immune Responses Following SARS-CoV-2 Infection.
Ursin RL; Shapiro JR; Klein SL
Trends Microbiol; 2020 Dec; 28(12):952-954. PubMed ID: 33077340
[TBL] [Abstract][Full Text] [Related]
32. Utilizing integrating network pharmacological approaches to investigate the potential mechanism of Ma Xing Shi Gan Decoction in treating COVID-19.
Wang YX; Ma JR; Wang SQ; Zeng YQ; Zhou CY; Ru YH; Zhang L; Lu ZG; Wu MH; Li H
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3360-3384. PubMed ID: 32271454
[TBL] [Abstract][Full Text] [Related]
33.
Stopsack KH; Mucci LA; Antonarakis ES; Nelson PS; Kantoff PW
Cancer Discov; 2020 Jun; 10(6):779-782. PubMed ID: 32276929
[No Abstract] [Full Text] [Related]
34. Age-related gene expression alterations by SARS-CoV-2 infection contribute to poor prognosis in elderly.
Bhattacharyya U; Thelma BK
J Genet; 2020; 99(1):. PubMed ID: 33168795
[TBL] [Abstract][Full Text] [Related]
35. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
Ochsner SA; Pillich RT; McKenna NJ
Sci Data; 2020 Sep; 7(1):314. PubMed ID: 32963239
[TBL] [Abstract][Full Text] [Related]
36. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.
Xiong Y; Liu Y; Cao L; Wang D; Guo M; Jiang A; Guo D; Hu W; Yang J; Tang Z; Wu H; Lin Y; Zhang M; Zhang Q; Shi M; Liu Y; Zhou Y; Lan K; Chen Y
Emerg Microbes Infect; 2020 Dec; 9(1):761-770. PubMed ID: 32228226
[TBL] [Abstract][Full Text] [Related]
37. A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: Potential implications for the SARS-CoV-2 modus operandi.
Vavougios GD
Med Hypotheses; 2020 Jul; 140():109759. PubMed ID: 32344305
[TBL] [Abstract][Full Text] [Related]
38. Telomeres and COVID-19.
Aviv A
FASEB J; 2020 Jun; 34(6):7247-7252. PubMed ID: 32427393
[TBL] [Abstract][Full Text] [Related]
39. Genome Scale-Differential Flux Analysis reveals deregulation of lung cell metabolism on SARS-CoV-2 infection.
Nanda P; Ghosh A
PLoS Comput Biol; 2021 Apr; 17(4):e1008860. PubMed ID: 33835998
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets.
Li Y; Duche A; Sayer MR; Roosan D; Khalafalla FG; Ostrom RS; Totonchy J; Roosan MR
BMC Genomics; 2021 Feb; 22(1):125. PubMed ID: 33602138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
